Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
The Journal of Urology
|
September 25, 2023
Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply
Kelly Bree, Neema Navai
Urology
|
November 10, 2020
EDITORIAL COMMENT
Kelly Bree, Surena F Matin
European Urology Focus
|
July 1, 2019
Systemic Treatment of Bone Disease in Metastatic Urinary Malignancies
Sunil H Patel, Justine Panian, Kelly Bree, et al.
BJU International
|
May 29, 2023
Bacillus Calmette-Guérin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?
Wei Shen Tan, Valentina Grajales, Kelly Bree, et al.
The Journal of Sexual Medicine
|
October 4, 2020
Genetic Variation in the Androgen Receptor Modifies the Association Between Testosterone and Vitality in Middle-Aged Men
Matthew S Panizzon, Kelly Bree, Tung-Chin Hsieh, et al.
European Urology Oncology
|
August 9, 2023
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy
Roberto Contieri, Patrick J Hensley, Wei Shen Tan, et al.
European Urology Open Science
|
July 13, 2023
Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
Wei Shen Tan, Valentina Grajales, Roberto Contieri, et al.
BJU International
|
February 20, 2024
Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy
Roberto Contieri, Wei Shen Tan, Valentina Grajales, et al.
European Urology Oncology
|
July 19, 2023
Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer
Wei Shen Tan, Ian M McElree, Facundo Davaro, et al.
BJU International
|
July 13, 2023
Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin
Roberto Contieri, Valentina Grajales, Wei Shen Tan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
The Journal of Urology
|
September 25, 2023
Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply
Kelly Bree, Neema Navai
Urology
|
November 10, 2020
EDITORIAL COMMENT
Kelly Bree, Surena F Matin
European Urology Focus
|
July 1, 2019
Systemic Treatment of Bone Disease in Metastatic Urinary Malignancies
Sunil H Patel, Justine Panian, Kelly Bree, et al.
BJU International
|
May 29, 2023
Bacillus Calmette-Guérin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?
Wei Shen Tan, Valentina Grajales, Kelly Bree, et al.
The Journal of Sexual Medicine
|
October 4, 2020
Genetic Variation in the Androgen Receptor Modifies the Association Between Testosterone and Vitality in Middle-Aged Men
Matthew S Panizzon, Kelly Bree, Tung-Chin Hsieh, et al.
European Urology Oncology
|
August 9, 2023
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy
Roberto Contieri, Patrick J Hensley, Wei Shen Tan, et al.
European Urology Open Science
|
July 13, 2023
Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
Wei Shen Tan, Valentina Grajales, Roberto Contieri, et al.
BJU International
|
February 20, 2024
Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy
Roberto Contieri, Wei Shen Tan, Valentina Grajales, et al.
European Urology Oncology
|
July 19, 2023
Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer
Wei Shen Tan, Ian M McElree, Facundo Davaro, et al.
BJU International
|
July 13, 2023
Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin
Roberto Contieri, Valentina Grajales, Wei Shen Tan, et al.
Page
of 2